Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLERIXAFOR vs POLATUZUMAB VEDOTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PLERIXAFOR vs POLATUZUMAB VEDOTIN: Safety Overview

Metric PLERIXAFOR POLATUZUMAB VEDOTIN
Total FAERS Reports 447 4,739
Deaths Reported 61 908
Death Rate 13.6% 19.2%
Hospitalizations 137 1,517
Average Patient Age 46.1 yrs 65.5 yrs
% Female Patients 53.5% 42.7%
FDA Approval Date Dec 15, 2008 N/A
Manufacturer Novadoz Pharmaceuticals LLC Genentech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription N/A